MacroGenics Inc (MGNX) stock news · rev $149.5M
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
This MGNX news page leads with what MacroGenics Inc filed — not a scraped headline mill.
No cached 8-K sentence for MGNX yet. We will not pad this page with generic market recap.
Latest reported MGNX revenue for 2025-12-31 was $149.5M. Net income was -$74.6M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. MGNX currently screens at market cap $246.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MGNX stock page; for the tape open the quote page.
MGNX stock news FAQ
What are MGNX's latest revenue and net income?
Latest cached MacroGenics Inc (MGNX) revenue for Dec 31, 2025 was $149.5M. Net income was -$74.6M. Statements: https://lician.com/financials/mgnx
How did MGNX revenue change from the prior cached period?
Cached MacroGenics Inc (MGNX) revenue was down 0.3% from $150.0M (Dec 31, 2024) to $149.5M (Dec 31, 2025). Statements: https://lician.com/financials/mgnx
What is MGNX's market cap?
MacroGenics Inc (MGNX) market cap is $246.6M on the latest cached fundamentals snapshot.
What kind of company is MGNX?
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Where is MGNX stock news listed?
Cached stock news for MacroGenics Inc (MGNX) is listed at https://lician.com/news/mgnx. Filings: https://lician.com/sec/mgnx
Not investment advice.